Novavax Inc. Stock Slips 4.2%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Novavax Inc. shed 4.2% to $8.42 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,067.17 and Dow Jones Industrial Average falling 1.3% to 52,759.21.

Novavax Inc. closed 29.7% short of its 52-week high of $11.97, which the company reached on February 26th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 2.2% to $267.37, Pfizer Inc. fell 1.6% to $27.79, and Merck & Co. Inc. fell 2.11% to $148.99.

Trading volume totaled 6.0 million, compared to the 50-day average of 3.8 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 20, 2026 16:35 ET (20:35 GMT)